연구동향 분석

Verigene Warfarin Metabolism Nucleic Acid Test Kit를 이용한 CYP2C9 및 VKORC1 유전형 분석능 평가

이혜영 김지연 이건동 박준홍 채효진 김명신 김용구 오용석 2014년

논문상세정보
인용/피인용

' Verigene Warfarin Metabolism Nucleic Acid Test Kit를 이용한 CYP2C9 및 VKORC1 유전형 분석능 평가' 의 참고문헌

  • Validation of clinical testing for warfarin sensitivity : comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms
    Langley MR J Mol Diagn 11 216-225 [2009]
  • The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements : proposal for a new dosing regimen
    Sconce EA Blood 106 2329-2333 [2005]
  • Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose
    King CR Am J Clin Pathol 129 876-883 [2008]
  • Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin
    Ma C Int J Hematol 96 719-728 [2012]
  • Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements
    Aquilante CL Clin Pharmacol Ther 79 291-302 [2006]
  • Hematology
    Cha YJ 654- [2011]
  • Genetic warfarin dosing : tables versus algorithms
    Finkelman BS J Am Coll Cardiol 57 612-618 [2011]
  • Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients
    Cho HJ Pharmacogenomics 8 329-337 [2007]
  • Evaluation of a microarray-based genotyping assay for the rapid detection of cytochrome P450 2C19 *2 and *3 polymorphisms from whole blood using nanoparticle probes
    Buchan BW Am J Clin Pathol 136 604-608 [2011]
  • Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
    Rieder MJ N Engl J Med 352 2285-2293 [2005]
  • Cytochrome P450 2C9polymorphisms: a comprehensive review of the in vitro and human data
    Lee CR Pharmacogenetics 12 251-263 [2002]
  • Comparison of performance of three commercial platforms for warfarin sensitivity genotyping
    Babic N Clin Chim Acta 406 143-147 [2009]
  • Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping
    Maurice CB Clin Chim Acta 411 947-954 [2010]
  • A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy
    Avery PJ Clin Pharmacol Ther 90 701-706 [2011]
  • A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
    D’Andrea G Blood 105 645-649 [2005]